MHC class II antigen presentation by dendritic cells regulated through endosomal sorting

Cold Spring Harbor Perspectives in Biology

Volumn 5, Issue 12, 2013, Pages

  ten Broeke, Toine ^b   Wubbolts, Richard ^a   Stoorvogel, Willem ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; ESCRT PROTEIN; HLA ANTIGEN CLASS 2;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; CD4+ T LYMPHOCYTE; DENDRITIC CELL; ENDOSOME; IMMUNOLOGY; INVARIANT CHAIN; LYSOSOME; REVIEW;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; ENDOSOMES; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYSOSOMES;

EID: 84889050260     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a016873     Document Type: Article

References (230)

1. Amigorena S, Savina A. 2010. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol 22: 109-117.
2. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J Exp Med 181: 1729-1741.
3. Anders A, Call MJ, Schulze MED, Fowler KD, Schubert DA, Seth NP, Sundberg EJ, Wucherpfennig KW. 2011. HLADM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol 12: 54-61.
4. Anderson MS, Miller J. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc Natl Acad Sci 89: 2282-2286.
5. Anderson HA, Roche PA. 1998. Phosphorylation regulates the delivery of MHC class II invariant chain complexes to antigen processing compartments. J Immunol 160: 4850-4858.
6. Anderson HA, Bergstralh DT, Kawamura T, Blauvelt A, Roche PA. 1999. Phosphorylation of the invariant chain by protein kinase C Regulates MHC class II trafficking to antigen-processing compartments. J Immunol 163: 5435-5443.
7. Anderson HA, Hiltbold EM, Roche PA. 2000. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat Immunol 1: 156-162.
8. Arunachalam B, Lamb CA, Cresswell P. 1994. Transport properties of free and MHC class ll-associated oligomers containing different isoforms of human invariant chain. Int Immunol 6: 439-451.
9. Ashman JB, Miller J. 1999. A role for the transmembrane domain in the trimerization of the MHC Class II-asso-ciated invariant chain. J Immunol 163: 2704-2712
10. Baravalle G, Park H, McSweeney M, Ohmura-Hoshino M, Matsuki Y, Ishido S, Shin JS. 2011. Ubiquitination of CD86 is a key mechanism in regulating antigen presentation by dendritic cells. J Immunol 187: 2966-2973
11. Bartee E, Mansouri M, Hovey Nerenberg BT, Gouveia K, Fruh K. 2004. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 78: 1109-1120
12. Beers C, Burich A, Kleijmeer MJ, Griffith JM, Wong P, Rudensky AY. 2005. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J Immunol 174: 1205-1212.
13. Beisner DR, Langerak P, Parker AE, Dahlberg C, Otero FJ, Sutton SE, Poirot L, Barnes W, Young MA, Niessen S, et al. 2013. The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of the invariant chain. J Exp Med 210: 23-30.
14. Benaroch P, Yilla M, Raposo G, Ito K, Miwa K, Geuze HJ, Ploegh HL. 1995. How MHC class II molecules reach the endocytic pathway. EMBO J 14: 37-49.
15. Berditchevski F, Odintsova E. 2007. Tetraspanins as regulators of protein trafficking. Traffic 8: 89-96.
16. 2 dendritic cells require the intramembrane endopeptidase SPPL2A. J Exp Med 210: 31-40.
17. Bevec T, Stoka V, Pungercic G, Dolenc I, Turk V. 1996. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L. J Exp Med 183: 1331-1338.
18. Bijlmakers MJ, Benaroch P, Ploegh HL. 1994. Mapping functional regions in the lumenal domain of the class II-associated invariant chain. J Exp Med 180: 623-629
19. + T cell selection in mice lacking invariant chain expression. J Exp Med 177: 1699-1712.
20. Blander JM, Medzhitov R. 2006. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812.
21. Blum JS, Wearsch PA, Cresswell P. 2013. Pathways of antigen processing. Annu Rev Immunol 31: 443-473.
22. Boes M, Cerny J, Massol R, Op dB, Kirchhausen T, Chen J, Ploegh HL. 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418: 983-988.
23. Boes M, Bertho N, Cerny J, Op den Brouw M, Kirchhausen T, Ploegh H. 2003. T cells induce extended class II MHC compartments in dendritic cells in a Toll-like receptordependent manner. J Immunol 171: 4081-4088.
24. Boes M, van der Wel N, Peperzak V, Kim Y, Peters PJ, Ploegh H. 2005. In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S. Eur J Immunol 35: 2552-2562.
25. Bonifacino JS, Traub LM. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annu Rev Biochem 72: 395-447.
26. Bosch B, Heipertz EL, Drake JR, Roche PA. 2013. MHC class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters. J Biol Chem 288: 13236-13242.
27. Bremnes B, Madsen T, Gedde-Dahl M, Bakke O. 1994. An LI and ML motif in the cytoplasmic tail of the MHC-associated invariant chain mediate rapid internalization. J Cell Sci 107: 2021-2032.
28. Busch R, Cloutier I, Sekaly RP, Hammerling GJ. 1996. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum. EMBO J 15: 418-428.
29. Buschow SI, Hoen ENMN, van Niel G, Pols MS, ten Broeke T, Lauwen M, Ossendorp F, Melief CJM, Raposo G, Wubbolts R, et al. 2009. MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic 10: 1528-1542.
30. Castellino F, Germain RN. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2: 73-88.
31. Charron DJ, Aellen-Schulz M, Geme JS III, Erlich HA, McDevitt HO. 1983. Biochemical characterization of an invariant polypeptide associated with Ia antigens in human and mouse. Mol Immunol 20: 21-32.
32. Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358: 764-768.
33. Choi NM, Majumder P, Boss JM. 2011. Regulation of major histocompatibility complex class II genes. Curr Opin Immunol 23: 81-87.
34. Chow A, Toomre D, Garrett W, Mellman I. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418: 988-994.
35. Cools N, Ponsaerts P, Van Tendeloo VFI, Berneman ZN. 2007. Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82: 1365-1374.
36. Costantino CM, Hang HC, Kent SC, Hafler DA, Ploegh HL. 2008. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation. J Immunol 180: 2876-2885.
37. Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA. 2005. Mechanisms of MHC class I-restricted antigen processing and cross-presentation. Immunol Rev 207: 145-157.
38. Crotzer VL, Blum JS. 2010. Autophagy and adaptive immunity. Immunology 131: 9-17.
39. De Gassart A, Camosseto V, Thibodeau J, Ceppi M, Catalan N, Pierre P, Gatti E. 2008. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation. Proc Natl Acad Sci 105: 3491-3496.
40. Dengjel J, Schoor O, Fischer R, Reich M, Kraus M, Muller M, Kreymborg K, Altenberend F, Brandenburg J, Kalbacher H, et al. 2005. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci 102: 7922-7927.
41. Denzin LK, Cresswell P. 1995. HLA-DM induces clip dissociation from MHC class II ab dimers and facilitates peptide loading. Cell 82: 155-165.
42. Denzin LK, Sant'Angelo DB, Hammond C, Surman MJ, Cresswell P. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278: 106-109.
43. Denzin LK, Fallas JL, Prendes M, Yi W. 2005. Right place, right time, right peptide: DO keeps DM focused. Immunol Rev 207: 279-292.
44. Draghi NA, Denzin LK. 2010. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc Natl Acad Sci 107: 16607-16612
45. Driessen C, Bryant RAR, Lennon-Duménil A, Villadangos JA, Bryant PW, Shi G, Chapman HA, Ploegh HL. 1999. Cathepsin S controls the trafficking and maturation of MHC Class II molecules in dendritic cells. J Cell Biol 147: 775-790.
46. Dugast M, Toussaint H, Dousset C, Benaroch P. 2005. AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J Biol Chem 280: 19656-19664
47. Elliott EA, Drake JR, Amigorena S, Elsemore J, Webster P, Mellman I, Flavell RA. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J Exp Med 179: 681-694.
48. El-Sukkari D, Wilson NS, Hakansson K, Steptoe RJ, Grubb A, Shortman K, Villadangos JA. 2003. The protease inhibitor Cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J Immunol 171: 5003-5011.
49. Engering A, Pieters J. 2001. Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells. Int Immunol 13: 127-134.
50. Falguières T, Luyet P, Gruenberg J. 2009. Molecular assemblies and membrane domains in multivesicular endosome dynamics. Exp Cell Res 315: 1567-1573
51. Freisewinkel IM, Schenck K, Koch N. 1993. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc Natl Acad Sci 90: 9703-9706.
52. Garg S, Sharma M, Ung C, Tuli A, Barral D, Hava D, Veerapen N, Besra G, Hacohen N, Brenner M. 2011. Lysosomal trafficking, antigen presentation, and microbial killing are controlled by the Arf-like GTPase Arl8b. Immunity 35: 182-193.
53. Gedde-Dahl M, Freisewinkel I, Staschewski M, Schenck K, Koch N, Bakke O. 1997. Exon 6 is essential for invariant chain trimerization and induction of large endosomal structures. J Biol Chem 272: 8281-8287.
54. Geppert T, Lipsky P. 1985. Antigen presentation by interferon-g-treated endothelial cells and fibroblasts: Differential ability to function as antigen-presenting cells despite comparable Ia expression. J Immunol 135: 3750-3762
55. Germain RN, Rinker AG. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363: 725-728.
56. Geuze HJ. 1998. The role of endosomes and lysosomes in MHC class II functioning. Immunol Today 19: 282-287
57. Glazier KS, Hake SB, Tobin HM, Chadburn A, Schattner EJ, Denzin LK. 2002. Germinal center B cells regulate their capability to present antigen by modulation of HLA-DO. J Exp Med 195: 1063-1069.
58. Griffin J, Chu R, Harding C. 1997. Early endosomes and a late endocytic compartment generate different peptideclass II MHC complexes via distinct processing mechanisms. J Immunol 158: 1523-1532.
59. Grotenbreg GM, Nicholson MJ, Fowler KD, Wilbuer K, Octavio L, Yang M, Chakraborty AK, Ploegh HL, Wucherpfennig KW. 2007. Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association. J Biol Chem 282: 21425-21436.
60. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. 2002. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667
61. Hammond C, Denzin LK, Pan M, Griffith JM, Geuze HJ, Cresswell P. 1998. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules. J Immunol 161: 3282-3291.
62. Henne W, Buchkovich N, Emr S. 2011. The ESCRT pathway. Dev Cell 21: 77-91.
63. Henne WM, Stenmark H, Emr SD. 2013. Molecular mechanisms of the membrane sculpting ESCRT pathway. Cold Spring Harb Perpsect Biol 5: a016766.
64. Hill CP, Babst M. 2012. Structure and function of the membrane deformation AAA ATPase Vps4. Biochim Biophys Acta 1823: 172-181.
65. Hoffmann E, Kotsias F, Visentin G, Bruhns P, Savina A, Amigorena S. 2012. Autonomous phagosomal degradation and antigen presentation in dendritic cells. Proc Natl Acad Sci 109: 14556-14561.
66. Hofmann MW, Honing S, Rodionov D, Dobberstein B, von Figura K, Bakke O. 1999. The leucine-based sorting motifs in the cytoplasmic domain of the invariant chain are recognized by the clathrin adaptors AP1 and AP2 and their medium chains. J Biol Chem 274: 36153-36158
67. Hornell TMC, Burster T, Jahnsen FL, Pashine A, Ochoa MT, Harding JJ, Macaubas C, Lee AW, Modlin RL, Mellins ED. 2006. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J Immunol 176: 3536-3547.
68. Howes MT, Mayor S, Parton RG. 2010. Molecules, mechanisms, and cellular roles of clathrin-independent endocytosis. Curr Opin Cell Biol 22: 519-527.
69. Hsing LC, Rudensky AY. 2005. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol Rev 207: 229-241.
70. Hurley JH. 2010. The ESCRT complexes. Crit Rev Biochem Mol Biol 45: 463-487.
71. Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas Ø, Nilsen NJ, Stenmark H, Latz E, Lien E, et al. 2010. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33: 583-596.
72. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subklewe M, Sauter B, Sheff D, et al. 1998. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188: 2163-2173.
73. Ishido S, Goto E, Matsuki Y, Ohmura-Hoshino M. 2009. E3 ubiquitin ligases for MHC molecules. Curr Opin Immunol 21: 78-83.
74. Jabbour M, Campbell EM, Fares H, Lybarger L. 2009. Discrete domains of MARCH1 mediate its localization, functional interactions, and posttranscriptional control of expression. J Immunol 183: 6500-6512.
75. Jabrane-Ferrat N, Nekrep N, Tosi G, Esserman L, Peterlin BM. 2003. MHC class II enhanceosome: How is the class II transactivator recruited to DNA-bound activators? Int Immunol 15: 467-475.
76. Jahnke M, Trowsdale J, Kelly AP. 2012. Structural requirements for recognition of major histocompatibility complex class II by membrane-associated RING-CH (MARCH) Protein E3 ligases. J Biol Chem 287: 28779-28789.
77. Joffre O, Nolte MA, Spörri R, Reis e Sousa C. 2009. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 227: 234-247
78. Joffre OP, Segura E, Savina A, Amigorena S. 2012. Crosspresentation by dendritic cells. Nat Rev Immunol 12: 557-569.
79. Jones PP, Murphy DB, Hewgill D, McDevitt HO. 1979. Detection of a common polypeptide chain in I-A and I-E sub-region immunoprecipitates. Mol Immunol 16:51-60.
80. Karacsonyi C, Knorr R, Fulbier A, Lindner R. 2004. Association of major histocompatibility complex II with cholesteroland sphingolipid-rich membranes precedes peptide loading. J Biol Chem 279: 34818-34826.
81. Karlsson L. 2005. DM and DO shape the repertoire of peptide-MHC-class-II complexes. Curr Opin Immunol 17: 65-70.
82. Keller AM, Groothuis TA, Veraar EAM, Marsman M, de Buy Wenniger LM, Janssen H, Neefjes J, Borst J. 2007. Costimulatory ligand CD70 is delivered to the immunological synapse by shared intracellular trafficking with MHC class II molecules. Proc Natl Acad Sci 104: 5989-5994
83. Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ. 1997. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 139: 639-649.
84. Kleijmeer M, Ramm G, Schuurhuis D, Griffith J, Rescigno M, Ricciardi-Castagnoli P, Rudensky AY, Ossendorp F, Melief CJM, Stoorvogel W, et al. 2001. Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells. J Cell Biol 155: 53-64
85. Knorr R, Karacsonyi C, Lindner R. 2009. Endocytosis of MHC molecules by distinct membrane rafts. J Cell Sci 122: 1584-1594.
86. Koch N, Lauer W, Habicht J, Dobberstein B. 1987. Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin. EMBO J 6: 1677-1683.
87. Koch N, Lipp J, Pessara U, Schenck K, Wraight C, Dobberstein B. 1989. MHC class II invariant chains in antigen processing and presentation. Trends Biochem Sci 14: 383-386.
88. Kondylis V, van Nispen tot Pannerden HE, van Dijk S, ten Broeke T, Wubbolts R, Geerts WJ, Seinen C, Mutis T, Heijnen HF. 2013. Endosome-mediated autophagy: An unconventional MIIC-driven autophagic pathway operational in dendritic cells. Autophagy 9: 861-880.
89. Kovalenko OV, Yang X, Kolesnikova TV, Hemler ME. 2004. Evidence for specific tetraspanin homodimers: Inhibition of palmitoylation makes cysteine residues available for cross-linking. Biochem J 377: 407-417.
90. Kreisel D, Richardson SB, Li W, Lin X, Kornfeld CG, Sugimoto S, Hsieh C, Gelman AE, Krupnick AS. 2010. Cutting edge: MHC class II expression by pulmonary nonhematopoietic cells plays a critical role in controlling local inflammatory responses. J Immunol 185: 3809-3813.
91. Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hämmerling GJ. 1996. Editing of the HLA-DRpeptide repertoire by HLA-DM. EMBO J 15: 6144-6154
92. Kropshofer H, Arndt SO, Moldenhauer G, Hämmerling GJ, Vogt AB. 1997. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 6: 293-302.
93. Kropshofer H, Vogt AB, Thery C, Armandola EA, Li B, Moldenhauer G, Amigorena S, Hammerling GJ. 1998. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 17: 2971-2981.
94. Kropshofer H, Spindeldreher S, Rohn TA, Platania N, Grygar C, Daniel N, Wolpl A, Langen H, Horejsi V, Vogt AB. 2002. Tetraspan microdomains distinct from lipid rafts enrich select peptideMHC class II complexes. Nat Immunol 3: 61-68.
95. {thorn} regulatory T cells. J Immunol 175: 6265-6270.
96. Kvist S, Wiman K, Claesson L, Peterson PA, Dobberstein B. 1982. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell 29: 61-69.
97. Lamb C, Cresswell P. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J Immunol 148: 3478-3482
98. Lapaque N, Hutchinson JL, Jones DC, Méresse S, Holden DW, Trowsdale J, Kelly AP. 2009a. Salmonella regulates polyubiquitination and surface expression of MHC class II antigens. Proc Natl Acad Sci 106: 14052-14057.
99. Lapaque N, Jahnke M, Trowsdale J, Kelly AP. 2009b. The HLA-DRa chain is modified by polyubiquitination. J Biol Chem 284: 7007-7016.
100. Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA, Karlsson L. 1996. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J 15: 4817-4824
101. Liljedahl M, Winqvist O, Surh CD, Wong P, Ngo K, Teyton L, Peterson PA, Brunmark A, Rudensky AY, Fung-Leung W, et al. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8: 233-243.
102. Lindner R. 2002. Transient surface delivery of invariant chain-MHC II complexes via endosomes: A quantitative study. Traffic 3: 133-146.
103. Lindner R, Unanue ER. 1996. Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J 15: 6910-6920.
104. Liu S, Marks MS, Brodsky FM. 1998. A dominant-negative clathrin mutant differentially affects trafficking of mole cules with distinct sorting motifs in the class II major histocompatibility complex (MHC) pathway. J Cell Biol 140: 1023-1037.
105. Lutz MB, Rovere P, Kleijmeer MJ, Rescigno M, Assmann CU, Oorschot VM, Geuze HJ, Trucy J, Demandolx D, Davoust J, et al. 1997. Intracellular routes and selective retention of antigens in mildly acidic cathepsin D/lysosome-associated membrane protein-1/MHC class II-positive vesicles in immature dendritic cells. J Immunol 159: 3707-3716
106. Ma JK, Platt MY, Eastham-Anderson J, Shin J, Mellman I. 2012. MHC class II distribution in dendritic cells and B cells is determined by ubiquitin chain length. Proc Natl Acad Sci 109: 8820-8827.
107. Maldonado RA, von Andrian UH. 2010. How tolerogenic dendritic cells induce regulatory T cells. Adv Immunol 108: 111-165.
108. {thorn} T cells. Immunity 36: 782-794.
109. Mantegazza AR, Magalhaes JG, Amigorena S, Marks MS. 2013. Presentation of phagocytosed antigens by MHC class I and II. Traffic 14: 135-152.
110. Marks MS, Blum JS, Cresswell P. 1990. Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens. J Cell Biol 111: 839-855.
111. Marks MS, Germain RN, Bonifacino JS. 1995. Transient aggregation of major histocompatibility complex class II chains during assembly in normal spleen cells. J Biol Chem 270: 10475-10481.
112. Matsuki Y, Ohmura-Hoshino M, Goto E, Aoki M, MitoYoshida M, Uematsu M, Hasegawa T, Koseki H, Ohara O, Nakayama M, et al. 2007. Novel regulation of MHC class II function in B cells. EMBO J 26: 846-854.
113. Mayor S, Pagano RE. 2007. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8: 603-612
114. McCormick PJ, Martina JA, Bonifacino JS. 2005. Involvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartments. Proc Natl Acad Sci 102: 7910-7915.
115. McGehee AM, Strijbis K, Guillen E, Eng T, Kirak O, Ploegh HL. 2011. Ubiquitin-dependent control of class II MHC localization is dispensable for antigen presentation and antibody production. PLoS ONE 6: e18817.
116. Menges M, Rössner S, Voigtländer C, Schindler H, Kukutsch NA, Bogdan C, Erb K, Schuler G, Lutz MB. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor a induce antigen-specific protection of mice from autoimmunity. J Exp Med 195: 15-22.
117. Mihelič M, Doberšek A, Gunčar G, Turk D. 2008. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation. J Biol Chem 283: 14453-14460.
118. Mulder DJ, Pooni A, Mak N, Hurlbut DJ, Basta S, Justinich CJ. 2011. Antigen presentation and MHC class II expression by human esophageal epithelial cells: Role in eosinophilic esophagitis. Am J Pathol 178: 744-753.
119. Murk JAN, Lebbink MN, Humbel BM, Geerts WJC, Griffith JM, Langenberg DML, Verreck FAW, Verkleij AJ, Koster AJ, Geuze HJ, et al. 2004. 3-D structure of multilaminar lysosomes in antigen presenting cells reveals trapping of MHC II on the internal membranes. Traffic 5: 936-945
120. Nakagawa T, Roth W, Wong P, Nelson A, Farr A, Deussing J, Villadangos JA, Ploegh H, Peters C, Rudensky AY. 1998. Cathepsin L: Critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280: 450-453.
121. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SRM, et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 10: 207-217.
122. Nathan JA, Lehner PJ. 2009. The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases. Exp Cell Res 315: 1593-1600.
123. Neefjes JJ, Ploegh HL. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance ab heterodimers in endosomes. EMBO J 11: 411-416.
124. Neefjes JJ, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL. 1990. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 61: 171-183.
125. Neefjes J, Jongsma MLM, Paul P, Bakke O. 2011. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11: 823-836
126. Nolte-'t Hoen ENM, Buschow SI, Anderton SM, Stoorvogel W, Wauben MHM. 2009. Activated T cells recruit exosomes secreted by dendritic cells via LFA-1. Blood 113: 1977-1981
127. Ocana-Morgner C, Wahren C, Jessberger R. 2009. SWAP-70 regulates RhoA/RhoB-dependent MHCII surface localization in dendritic cells. Blood 113: 1474-1482
128. Odorizzi CG, Trowbridge IS, Xue L, Hopkins CR, Davis CD, Collawn JF. 1994. Sorting signals in the MHC class II invariant chain cytoplasmic tail and transmembrane region determine trafficking to an endocytic processing compartment. J Cell Biol 126: 317-330.
129. Oh J, Wu N, Baravalle G, Cohn B, Ma J, Lo B, Mellman I, Ishido S, Anderson M, Shin JS. 2013. MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. J Exp Med 210: 1069-1077.
130. Ohmura-Hoshino M, Matsuki Y, Aoki M, Goto E, Mito M, Uematsu M, Kakiuchi T, Hotta H, Ishido S. 2006. Inhibition of MHC class II expression and immune responses by c-MIR. J Immunol 177: 341-354.
131. Ohmura-Hoshino M, Matsuki Y, Mito-Yoshida M, Goto E, Aoki-Kawasumi M, Nakayama M, Ohara O, Ishido S. 2009. Cutting edge: Requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells. J Immunol 183: 6893-6897.
132. O'Sullivan DM, Noonan D, Quaranta V. 1987. Four Ia invariant chain forms derive from a single gene by alternate splicing and alternate initiation of transcription/translation. J Exp Med 166: 444-460.
133. Owen MJ, Kissonerghis AM, Lodish HF, Crumpton MJ. 1981. Biosynthesis and maturation of HLA-DR antigens in vivo. J Biol Chem 256: 8987-8993.
134. Pathak SS, Blum JS. 2000. Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules. Traffic 1: 561-569.
135. Paul P, van den Hoorn T, Jongsma MM, Bakker M, Hengeveld R, Janssen L, Cresswell P, Egan D, van Ham M, ten Brinke A, et al. 2011. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell 145: 268-283.
136. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. 1991. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 349: 669-676.
137. Peterson M, Miller J. 1992. Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41. Nature 357: 596-598.
138. Pierre P, Mellman I. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 93: 1135-1145
139. Pieters J, Horstmann H, Bakke O, Griffiths G, Lipp J. 1991. Intracellular transport and localization of major histocompatibility complex class II molecules and associated invariant chain. J Cell Biol 115: 12131223.
140. Pieters J, Bakke O, Dobberstein B. 1993. The MHC class II associated invariant chain contains two endosomal targeting signals within its cytoplasmic tail. J Cell Sci 106: 831-846.
141. Pinet V, Vergelli M, Martini R, Bakke O, Long EO. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 375: 603-606.
142. Piper RC, Katzmann DJ. 2007. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23: 519-547.
143. Piper RC, Dikic I, Lukacs G. 2014. Ubiquitin-dependent sorting in endocytosis. Cold Spring Harb Perspect Biol doi: 10.1101/cshperspect.a016808.
144. Pober JS, Collins T, Gimbrone MA, Cotran RS, Gitlin JD, Fiers W, Clayberger C, Krensky AM, Burakoff SJ, Reiss CS. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305: 726-729.
145. Poloso NJ, Denzin LK, Roche PA. 2006. CDw78 defines MHC class II-peptide complexes that require Ii chaindependent lysosomal trafficking, not localization to a specific tetraspanin membrane microdomain. J Immunol 177: 5451-5458.
146. Pond L, Watts C. 1997. Characterization of transport of newly assembled, T-cell-stimulatory MHC class II-peptide complexes from MHC class II compartments to the cell surface. J Immunol 159: 543-553.
147. Pond L, Watts C. 1999. Functional early endosomes are required for maturation of major histocompatibility complex class II molecules in human B lymphoblastoid cells. J Biol Chem 274: 18049-18054.
148. -dendritic cells. J Immunol 187: 4151-4160.
149. Rabinowitz JD, Vrljic M, Kasson PM, Liang MN, Busch R, Boniface JJ, Davis MM, McConnell HM. 1998. Formation of a highly peptide-receptive state of class II MHC. Immunity 9: 699-709.
150. Raiborg C, Stenmark H. 2009. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 458: 445-452.
151. Raposo G, Stoorvogel W. 2013. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200: 373-383.
152. Reid PA, Watts C. 1990. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature 346: 655-657.
153. Reid PA, Watts C. 1992. Constitutive endocytosis and recycling of major histocompatibility complex class II glycoproteins in human B-lymphoblastoid cells. Immunology 77: 539-542.
154. Reis e Sousa C. 2006. Dendritic cells in a mature age. Nat Rev Immunol 6: 476-483.
155. Reith W, LeibundGut-Landmann S, Waldburger J. 2005. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 5: 793-806
156. Riberdy JM, Newcomb JR, Surman MJ, Barbosat JA, Cresswell P. 1992. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360: 474-477.
157. Riese RJ, Wolf PR, Brömme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4: 357-366
158. Rocha N, Kuijl C, van der Kant R, Janssen L, Houben D, Janssen H, Zwart W, Neefjes J. 2009. Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILPp150Glued and late endosome positioning. J Cell Biol 185: 1209-1225.
159. Roche PA, Cresswell P. 1990. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding. Nature 345: 615-618.
160. Roche PA, Cresswell P. 1991. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc Natl Acad Sci 88: 3150-3154.
161. Roche PA, Teletski CL, Stang E, Bakke O, Long EO. 1993. Cell surface HLA-DR-invariant chain complexes are targeted to endosomes by rapid internalization. Proc Natl Acad Sci 90: 8581-8585.
162. Rodgers W, Smith K. 2005. Properties of glycolipid-enriched membrane rafts in antigen presentation. Crit Rev Immunol 25: 19-30.
163. Rodionov DG, Bakke O. 1998. Medium chains of adaptor complexes AP-1 and AP-2 recognize leucine-based sorting signals from the invariant chain. J Biol Chem 273: 6005-6008.
164. Romagnoli P, Germain RN. 1994. The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J Exp Med 180: 1107-1113.
165. Romieu-Mourez R, Francois M, Boivin M, Stagg J, Galipeau J. 2007. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-g, TGF-b, and cell density. J Immunol 179: 1549-1558.
166. Rudd CE, Bodmer JG, Bodmer WF, Crumpton MJ. 1985. HLA-D region antigen-associated invariant polypeptides as revealed by two-dimensional gel analysis. Glycosylation and structural inter-relationships. J Biol Chem 260: 1927-1936.
167. Rudensky AY, Preston-Hurlburt P, Hong S, Barlow A, Janeway CA. 1991. Sequence analysis of peptides bound to MHC class II molecules. Nature 353: 622-627
168. Salamero J, Borgne RL, Saudrais C, Goud B, Hoflack B. 1996. Expression of major histocompatibility complex class II molecules in HeLa cells promotes the recruitment of AP-1 Golgi-specific assembly proteins on Golgi membranes. J Biol Chem 271: 30318-30321.
169. Santambrogio L, Potolicchio I, Fessler SP, Wong S, Raposo G, Strominger JL. 2005. Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells. Nat Immunol 6: 1020-1028.
170. Schaiff WT, Hruska KA, McCourt DW, Green M, Schwartz BD. 1992. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J Exp Med 176: 657-666.
171. Schmidt SV, Nino-Castro AC, Schultze JL. 2012. Regulatory dendritic cells: There is more than just immune activation. Front Immunol 3: 274.
172. Schneppenheim J, Dressel R, Huttl S, Lullmann-Rauch R, Engelke M, Dittmann K, Wienands J, Eskelinen E, Hermans-Borgmeyer I, Fluhrer R, et al. 2013. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traffic by cleavage of the invariant chain. J Exp Med 210: 41-58.
173. Schulze ME, Wucherpfennig KW. 2012. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr Opin Immunol 24: 105-111.
174. Segura E, Villadangos JA. 2011. A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic 12: 1677-1685.
175. {thorn} dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 179: 1489-1496.
176. Sekaly RP, Tonnelle C, Strubin M, Mach B, Long EO. 1986. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain. J Exp Med 164: 1490-1504.
177. Sette A, Ceman S, Kubo RT, Sakaguchi K, Appella E, Hunt DF, Davis TA, Michel H, Shabanowitz J, Rudersdorf R. 1992. Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258: 1801-1804.
178. Sherman MA, Weber DA, Jensen PE. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3: 197-205
179. Shi G, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10: 197-206
180. Shi G, Bryant RAR, Riese R, Verhelst S, Driessen C, Li Z, Bromme D, Ploegh HL, Chapman HA. 2000. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J Exp Med 191: 1177-1186.
181. Shin JS, Ebersold M, Pypaert M, Delamarre L, Hartley A, Mellman I. 2006. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444: 115-118.
182. Simonsen A, Pedersen KW, Nordeng TW, von der Lippe A, Stang E, Long EO, Bakke O. 1999. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the b-chain. J Immunol 163: 2540-2548.
183. Skjeldal FM, Strunze S, Bergeland T, Walseng E, Gregers TF, Bakke O. 2012. The fusion of early endosomes induces molecular-motor-driven tubule formation and fission. J Cell Sci 125: 1910-1919.
184. Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375: 802-806.
185. Sorkin A, von Zastrow M. 2009. Endocytosis and signalling: Intertwining molecular networks. Nat Rev Mol Cell Biol 10: 609-622.
186. Spiro R, Quaranta V. 1989. The invariant chain is a phosphorylated subunit of class II molecules. J Immunol 143: 2589-2594.
187. Steinman RM, Hawiger D, Nussenzweig MC. 2003. Tolerogenic dendritic cells. Annu Rev Immunol 21: 685-711
188. Strubin M, Berte C, Mach B. 1986. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J 5: 3483-3488.
189. Tan JKH, O'Neill HC. 2005. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J Leukoc Biol 78: 319-324.
190. ten Broeke T, de Graaff A, van'T Veld EM, Wauben MH, Stoorvogel W, Wubbolts R. 2010. Trafficking of MHC class II in dendritic cells is dependent on but not regulated by degradation of its associated invariant chain. Traffic 11: 324-331.
191. ten Broeke T, van Niel G, Wauben MHM, Wubbolts R, Stoorvogel W. 2011. Endosomally stored MHC class II does not contribute to antigen presentation by dendritic cells at inflammatory conditions. Traffic 12: 1025-1036
192. Teyton L, O'Sullivan D, Dickson PW, Lotteau V, Sette A, Fink P, Peterson PA. 1990. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways. Nature 348: 39-44.
193. Théry C, Brachet V, Regnault A, Rescigno M, Ricciardi-Castagnoli P, Bonnerot C, Amigorena S. 1998. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the aand b-chains. J Immunol 161: 2106-2113.
194. {thorn} T cells by dendritic cell-derived exosomes. Nat Immunol 3: 1156-1162
195. Théry C, Zitvogel L, Amigorena S. 2002b. Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2: 569-579.
196. Thibodeau J, Bourgeois-Daigneault M, Huppé G, Tremblay J, Aumont A, Houde M, Bartee E, Brunet A, Gauvreau M, de Gassart A, et al. 2008. Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes. Eur J Immunol 38: 1225-1230
197. Trombetta ES, Mellman I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23: 975-1028.
198. Tze LE, Horikawa K, Domaschenz H, Howard DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S, Andoniou CE, et al. 2011. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J Exp Med 208: 149-165.
199. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401: 811-815.
200. Unternaehrer JJ, Chow A, Pypaert M, Inaba K, Mellman I. 2007. The tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surface. Proc Natl Acad Sci 104: 234-239.
201. van Ham SM, Tjin EPM, Lillemeier BF, Gruneberg U, van Meijgaarden KE, Pastoors L, Verwoerd D, Tulp A, Canas B, Rahman D, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr Biol 7: 950-957.
202. van Ham M, van Lith M, Lillemeier B, Tjin E, Gruneberg U, Rahman D, Pastoors L, van Meijgaarden K, Roucard C, Trowsdale J, et al. 2000. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (Hla)-Do. J Exp Med 191: 1127-1136.
203. van Lith M, McEwen-Smith RM, Benham AM. 2010. HLADP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM. J Biol Chem 285: 40800-40808.
204. van Niel G, Wubbolts R, ten Broeke T, Buschow SI, Ossendorp FA, Melief CJ, Raposo G, van Balkom BW, Stoorvogel W. 2006. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25: 885-894.
205. van Niel G, Wubbolts R, Stoorvogel W. 2008. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells. Curr Opin Cell Biol 20: 437-444
206. van Nispen tot Pannerden, HE, Geerts WJ, Kleijmeer MJ, Heijnen HFG. 2010. Spatial organization of the transforming MHC class II compartment. Biol Cell 102: 581-591.
207. Vergelli M, Pinet V, Vogt AB, Kalbus M, Malnati M, Riccio P, Long EO, Martin R. 1997. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur J Immunol 27: 941-951
208. Villadangos JA, Riese RJ, Peters C, Chapman HA, Ploegh HL. 1997. Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J Exp Med 186: 549-560.
209. Villadangos JA, Driessen C, Shi G, Chapman HA, Ploegh HL. 2000. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H2DM. EMBO J 19: 882-891.
210. Villadangos JA, Cardoso M, Steptoe RJ, van Berkel D, Pooley J, Carbone FR, Shortman K. 2001. MHC class II expression is regulated in dendritic cells independently of invariant chain degradation. Immunity 14: 739-749.
211. Villadangos JA, Schnorrer P, Wilson NS. 2005. Control of MHC class II antigen presentation in dendritic cells: A balance between creative and destructive forces. Immunol Rev 207: 191-205.
212. Viville S, Neefjes J, Lotteau V, Dierich A, Lemeur M, Ploegh H, Benoist C, Mathis D. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72: 635-648
213. Vyas JM, Kim Y, Artavanis-Tsakonas K, Love JC, Van der Veen AG, Ploegh HL. 2007. Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells. J Immunol 178: 7199-7210.
214. Walseng E, Bakke O, Roche PA. 2008. Major histocompatibility complex class II-peptide complexes internalize using a clathrinand dynamin-independent endocytosis pathway. J Biol Chem 283: 14717-14727.
215. Walseng E, Furuta K, Bosch B, Weih KA, Matsuki Y, Bakke O, Ishido S, Roche PA. 2010a. Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells. Proc Natl Acad Sci 107: 20465-20470.
216. Walseng E, Furuta K, Goldszmid RS, Weih KA, Sher A, Roche PA. 2010b. Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus. J Biol Chem 285: 41749-41754.
217. Wang K, Peterson PA, Karlsson L. 1997. Decreased endosomal delivery of major histocompatibility complex class II-invariant chain complexes in dynamin-deficient cells. J Biol Chem 272: 17055-17060.
218. Warmerdam PA, Long EO, Roche PA. 1996. Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments. J Cell Biol 133: 281-291.
219. Watts C. 2012. The endosomelysosome pathway and information generation in the immune system. Biochim Biophys Acta 1824: 14-21.
220. Weber DA, Evavold BD, Jensen PE. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274: 618-621.
221. West MA, Wallin RPA, Matthews SP, Svensson HG, Zaru R, Ljunggren H, Prescott AR, Watts C. 2004. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305: 1153-1157.
222. Wilson JE, Katkere B, Drake JR. 2009. Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages. Infect Immun 77: 4953-4965.
223. Wubbolts R, Fernandez-Borja M, Oomen L, Verwoerd D, Janssen H, Calafat J, Tulp A, Dusseljee S, Neefjes J. 1996. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface. J Cell Biol 135: 611-622.
224. Wubbolts R, Fernandez-Borja M, Jordens I, Reits E, Dusseljee S, Echeverri C, Vallee RB, Neefjes J. 1999. Opposing motor activities of dynein and kinesin determine retention and transport of MHC class II-containing compartments. J Cell Sci 112: 785-795.
225. Yáñez-Mó M, Barreiro O, Gordon-Alonso M, Sala-Valdés M, Sánchez-Madrid F. 2009. Tetraspanin-enriched microdomains: A functional unit in cell plasma membranes. Trends Cell Biol 19: 434-446.
226. Yi W, Seth NP, Martillotti T, Wucherpfennig KW, Sant'Angelo DB, Denzin LK. 2010. Targeted regulation of selfpeptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J Clin Invest 120: 1324-1336.
227. Young LJ, Wilson NS, Schnorrer P, Proietto A, ten Broeke T, Matsuki Y, Mount AM, Belz GT, O'Keeffe M, Ohmura-Hoshino M, et al. 2008. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nat Immunol 9: 1244-1252.
228. Zhong G, Romagnoli P, Germain RN. 1997. Related leucinebased cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J Exp Med 185: 429-438.
229. Zilber M, Setterblad N, Vasselon T, Doliger C, Charron D, Mooney N, Gelin C. 2005. MHC class II/CD38/CD9: A lipid-raft-dependent signaling complex in human monocytes. Blood 106: 3074-3081.
230. Zwart W, Griekspoor A, Kuijl C, Marsman M, van Rheenen J, Janssen H, Calafat J, van Ham M, Janssen L, van Lith M, et al. 2005. Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape. Immunity 22: 221-233.